These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31766664)

  • 1. Animal Models of Type III Secretion System-Mediated Pathogenesis.
    Hotinger JA; May AE
    Pathogens; 2019 Nov; 8(4):. PubMed ID: 31766664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies Inhibiting the Type III Secretion System of Gram-Negative Pathogenic Bacteria.
    Hotinger JA; May AE
    Antibodies (Basel); 2020 Jul; 9(3):. PubMed ID: 32726928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria.
    Keyser P; Elofsson M; Rosell S; Wolf-Watz H
    J Intern Med; 2008 Jul; 264(1):17-29. PubMed ID: 18393958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial adhesion and host cell factors leading to effector protein injection by type III secretion system.
    Bohn E; Sonnabend M; Klein K; Autenrieth IB
    Int J Med Microbiol; 2019 Jul; 309(5):344-350. PubMed ID: 31178419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria.
    Ashida H; Sasakawa C
    Front Cell Infect Microbiol; 2015; 5():100. PubMed ID: 26779450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type III Secretion in the Melioidosis Pathogen
    Vander Broek CW; Stevens JM
    Front Cell Infect Microbiol; 2017; 7():255. PubMed ID: 28664152
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthetic Cyclic Peptomers as Type III Secretion System Inhibitors.
    Lam H; Schwochert J; Lao Y; Lau T; Lloyd C; Luu J; Kooner O; Morgan J; Lokey S; Auerbuch V
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topological Analysis of the Type 3 Secretion System Translocon Pore Protein IpaC following Its Native Delivery to the Plasma Membrane during Infection.
    Russo BC; Duncan JK; Goldberg MB
    mBio; 2019 May; 10(3):. PubMed ID: 31138750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity.
    Sheahan KL; Isberg RR
    mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Mechanism for Protein Delivery by the Type 3 Secretion System for Extracellularly Secreted Proteins.
    Tejeda-Dominguez F; Huerta-Cantillo J; Chavez-Dueñas L; Navarro-Garcia F
    mBio; 2017 Mar; 8(2):. PubMed ID: 28351918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Labeling Enzyme Tags for Analyses of Translocation of Type III Secretion System Effector Proteins.
    Göser V; Kommnick C; Liss V; Hensel M
    mBio; 2019 Jun; 10(3):. PubMed ID: 31239375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shutting Down Shigella Secretion: Characterizing Small Molecule Type Three Secretion System ATPase Inhibitors.
    Case HB; Mattock DS; Dickenson NE
    Biochemistry; 2018 Dec; 57(50):6906-6916. PubMed ID: 30460850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural compound sanguinarine chloride targets the type III secretion system of
    Zhang Y; Liu Y; Wang T; Deng X; Chu X
    Biochem Biophys Rep; 2018 Jul; 14():149-154. PubMed ID: 29761161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression by Lawsonia intracellularis of type III secretion system components during infection.
    Alberdi MP; Watson E; McAllister GE; Harris JD; Paxton EA; Thomson JR; Smith DG
    Vet Microbiol; 2009 Nov; 139(3-4):298-303. PubMed ID: 19589649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Third Transmembrane Domain of EscR Is Critical for Function of the Enteropathogenic
    Tseytin I; Madar A; Mitrovic B; Deng W; Finlay BB; Sal-Man N
    mSphere; 2018 Jul; 3(4):. PubMed ID: 30045964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Transcriptional Regulator HlyU Positively Regulates Expression of
    Getz LJ; Thomas NA
    J Bacteriol; 2018 Aug; 200(15):. PubMed ID: 29440251
    [No Abstract]   [Full Text] [Related]  

  • 17. Negative Autogenous Control of the Master Type III Secretion System Regulator HrpL in Pseudomonas syringae.
    Waite C; Schumacher J; Jovanovic M; Bennett M; Buck M
    mBio; 2017 Jan; 8(1):. PubMed ID: 28119474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin gallate inhibits the type III secretion system of Gram-negative enteropathogenic bacteria under model conditions.
    Nakasone N; Higa N; Toma C; Ogura Y; Suzuki T; Yamashiro T
    FEMS Microbiol Lett; 2017 Jul; 364(13):. PubMed ID: 28651361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron availability and oxygen tension regulate the Yersinia Ysc type III secretion system to enable disseminated infection.
    Hooker-Romero D; Mettert E; Schwiesow L; Balderas D; Alvarez PA; Kicin A; Gonzalez AL; Plano GV; Kiley PJ; Auerbuch V
    PLoS Pathog; 2019 Dec; 15(12):e1008001. PubMed ID: 31869388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Bordetella Secreted Regulator BspR Is Translocated into the Nucleus of Host Cells via Its N-Terminal Moiety: Evaluation of Bacterial Effector Translocation by the Escherichia coli Type III Secretion System.
    Abe A; Nishimura R; Tanaka N; Kurushima J; Kuwae A
    PLoS One; 2015; 10(8):e0135140. PubMed ID: 26247360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.